ALCAR is N-acetyl-L-carnitine, a form of L-carnitine found ubiquitously in mammalian tissues that is important for energy production. Extensive research has documented ALCAR’s ability to improve mitochondrial function, sperm production and energy production. ALCAR is unique because it is able to cross the blood-brain barrier more easily than L-carnitine, making it more effective for enhancing cognitive function. Research has found ALCAR to be capable of reducing the symptoms of mild cognitive impairment by improving memory, attention, mood and other cognitive functions. Amazingly, the positive cognitive effects seem to persist even after stopping short-term supplementation.
ALCAR can also increase L-carnitine levels in those who are deficient due to factors such as the use of certain medications, disease, a strict vegetarian diet, and heart or circulatory conditions. Some people use L-carnitine for athletic performance and endurance as it promotes energy production and proper fat burning. Muscle fatigue, male infertility (due to poor sperm health), Rett syndrome, chronic fatigue syndrome, anorexia, attention deficit-hyperactivity disorder (ADHD), thyroid imbalances, leg ulcers, high cholesterol and Lyme disease are all common conditions that may benefit from ALCAR supplementation.
N-Acetyl-L-Carnitine (HCl) - 500 mg
sodium stearyl fumarate. Capsule: hypromellose.
Take two to four capsules daily with food, or as directed by a qualified health care practitioner. A minimum of three months may be required before observing an effect.
This product provides 1.59 g of single amino acid per day. Consult a health care practitioner prior to use if you are pregnant, breastfeeding, have liver or kidney disease, have been instructed to follow a low protein diet, if symptoms persist or worsen or for use beyond six months.
Feelings of overstimulation and/or sleeplessness may occur, in which case discontinue use if symptoms persist or worsen. Low incidence of seizures has been reported with oral doses in individuals with or without a pre-existing seizure disorder. Mild gastrointestinal symptoms (transient nausea, vomiting, abdominal cramps and diarrhea) have been reported. Body odour, flatulence, increased appetite or rash may occur.